Explore federal awards
Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
Export these results to CSV · 9 matching records
FIRST-IN-CLASS SMALL MOLECULE CANDIDATE NCGC72 (CD206 AGONIST) FOR IMMUNOLOGICALLY COLD SOLID ORGAN CANCERSDepartment of Health and Human Services$547.0K obligationsEnds Dec 31, 2025
NON-CLINICAL SAFETY ASSESSMENT OF DRINABANT, A CANNABINOID RECEPTOR (CB-1) ANTAGONIST, FOR ACUTE CANNABINOID OVERDOSE (ACO). POP: 09/25/2020 TO 03/24/2021.Department of Health and Human Services$751.4K obligationsEnds Dec 31, 2024
IITRI - PERFORMANCE AREA 1 TO2Department of Health and Human Services$212.5K obligationsEnds Feb 28, 2027
PTTP TASK ORDER - IITRI - MS RODENT AND NON-RODENT MTD-DRF STUDIESDepartment of Health and Human Services$401.4K obligationsEnds Sep 25, 2026
IITRI - NON-GLP DOSE RANGE FINDING (DRF) STUDIES-DEC. 2023 #2Department of Health and Human Services$202.0K obligationsEnds Jun 2, 2025
NON-CLINICAL SAFETY ASSESSMENT OF COVALENT BI-TOX TO SUPPORT NEUROPATHIC PAIN INDICATIONDepartment of Health and Human Services$766.0K obligationsEnds Apr 29, 2025
NON-CLINICAL SAFETY OF PTH-1A, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE. POP: 09/16/2020 TO 03/15/2020.Department of Health and Human Services$3.1M obligationsEnds Sep 30, 2024
TASK ORDER TITLE: NON-CLINICAL SAFETY OF MITRAGYNINE TO SUPPORT ITS FUTURE ORAL THERAPY FOR ANALGESIA INDICATION. POP: 09/17/2020 TO 03/16/2022.Department of Health and Human Services$2.4M obligationsEnds Oct 31, 2025
IITRI - PTTP DRF BPN STUDY - TO3Department of Health and Human Services$438.1K obligationsEnds Feb 28, 2025